Journals / Turkish Journal of Gastroenterology / 2006 / Cilt: 17 - Sayı: 1

Akalazyada malignite riskinin ve endoskopik takibin bir vaka nedeni ile değerlendirilmesi

Evaluation of malignancy risk and endoscopic follow up in achalasia: Case report

Pages
46–49
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In conclusion, endoscopic follow up is necessary for these patients even after surgical treatment.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Achalasia is an esophageal motility disorder that is accepted as a risk factor for the development of cancer.
📊
Key Findings & Data:Especially in megaesophagus, chronic irritation of foods and bacterial overgrowth may contribute to the formation of high-grade dysplasia and squamous cell carcinoma.
💡
Conclusion & Impact:In conclusion, endoscopic follow up is necessary for these patients even after surgical treatment.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Özofagus akalazisi · Endoskopi · Esophageal Achalasia

Abstract

Achalasia is an esophageal motility disorder that is accepted as a risk factor for the development of cancer. Especially in megaesophagus, chronic irritation of foods and bacterial overgrowth may contribute to the formation of high-grade dysplasia and squamous cell carcinoma. We present a case of advanced stage achalasia with high-grade dysplasia detected three years after a cardiomyotomy operation. Cancer risk continues after surgical operation in achalasia, like in this case. In conclusion, endoscopic follow up is necessary for these patients even after surgical treatment.

Özet

Akalazya, kanser gelişimi için risk faktörü olarak kabul edilen özofagusun motilite bozukluğu ile ilişkili bir hastalıktır. Özellikle megaözofagusda, lümen içindeki gıdaların kronik iritasyonu ve bakteriyal aşırı gelişim yüksek dereceli displazi ve skuamöz hücreli karsinom gelişimine zemin hazırlayabilir. Bu yazı da kardiyomyotomi operasyonundan 3 yıl sonra yüksek derecede displazi saptanan ileri dönemdeki bir akalazya vakasını sunuyoruz. Kanser riski, bu vakada görüldüğü gibi operasyon sonrasında da devam etmektedir. Sonuç olarak cerrahi tedaviden sonra bile endoskopik takip gereklidir.

🔖

Cite This Article

AKYÜZ, F., İBRİŞİM, D., BALIK, E., YONAL, O., KAYMAKOĞLU, S., BUĞRA, D., MUNGAN, Z. (2006). Akalazyada malignite riskinin ve endoskopik takibin bir vaka nedeni ile değerlendirilmesi. Turkish Journal of Gastroenterology, Cilt: 17 - Sayı: 1, 46–49. https://ajindex.com/articles/409990

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Vaezi MF, Richter JE. Diagnosis and management of achalasia. Am J Gastroenterol 1999; 94: 3406-12
  2. Parkman HP, Reynolds JC, Ouyang A, et al. Pneumatic dilatation or esophagocardiomyotomy treatment for idiopathic achalasia: clinical outcomes and cost analysis. Dig Dis Sci 1993; 38: 75-85
  3. Urbach DR, Hansen PD, Khajanchee YS, Swanstrom LL. A decision analysis of the optimal initial approach to achalasia: laparoscopic Heller cardiomyotomy with partial fundoplication, thoracoscopic Heller cardiomyotomy, pneumatic dilatation, or botulinum toxin injection. J Gastrointest Surg 2001; 5: 192-205
  4. Brücher BLDM, Stein HJ, Bartels H, et al. Achalasia and esophageal cancer: incidence, prevalence and prognosis. Worl J Surg 2001; 25: 745-9
  5. Guo JP, Gilman PB, Thomas RM, et al. Barrett's esophagus and achalasia. J Clin Gastroenterol 2002; 34: 439-43
  6. Ellis FH Jr, Gibb SP, Balogh K, Schwaber JR. Esophageal achalasia and adenocarcinoma in Barrett's esophagus: A report of two cases and a review of the literature. Dis Esophagus 1997; 10: 55-60
  7. Fagge CH. A case of simple stenosis of the oesophagus, followed by epithelioma. Guy’s Hosp Rep 1872; 17: 413
  8. Pajecki D, Zilberstein B, dos Santos MA, et al. Megaesophagus microbiota: A qualitative and quantitative analysis. J Gastrointest Surg 2002; 6: 723-9
  9. Liu JF, Zhang J, Tian ZQ, et al. Long-term outcome of esophageal cardiomyotomy for achalasia.World J Gastroenterol 2004; 10: 287-91
  10. Achkar E, Richter J. Diagnosis and follow-up of patients with achalasia. Am J Gastroenterol 2003; 98: 696-7
  11. Aggestrup S, Holm JC, Sorensen HR. Does achalasia predispose to cancer of the esophagus? Chest 1992; 102: 1013- 6
  12. Yamamuro EM, Cecconello I, Iriya K, et al. Lugol dye endoscopy for analysis of esophageal mucosa in achalasia. Hepatogastroenterol 1999; 46: 1687-91
  13. Farr CM. Achalasia and esophageal carcinoma. Am J Gastroenterol 1994; 89: 1600-1
  14. Sandler RS, Nyren O, Ekbom A, et al. The risk of esophageal cancer in patients with achalasia: a population basedstudy. JAMA 1995; 274: 1359-62
  15. Spechler ST. Dysplasia in Barrett’s esophagus: limitations of current management strategies. Am J Gastroenterol 2005; 100: 927-35.